TACC2 anticorps (AA 237-303)
Aperçu rapide pour TACC2 anticorps (AA 237-303) (ABIN1886240)
Antigène
Voir toutes TACC2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 237-303
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Synthetic peptide contain a sequence corresponding to a region within amino acids 237 and 303 of Human TACC2
-
-
-
-
Indications d'application
-
Suggested dilutions:
Western blotting: 1.500-1.3000
Immunohistochemistry: 1.100-1.250 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- TACC2 (Transforming, Acidic Coiled-Coil Containing Protein 2 (TACC2))
-
Autre désignation
- TACC2
-
Sujet
-
Transforming acidic coiled-coil proteins are a conserved family of centrosome- and microtubule-interacting proteins that are implicated in cancer.This gene encodes a protein that concentrates at centrosomes throughout the cell cycle.This gene lies within a chromosomal region associated with tumorigenesis.Expression of this gene is induced by erythropoietin and is thought to affect the progression of breast tumors.Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq]
-
Poids moléculaire
- 119 kDa
-
ID gène
- 10579
-
NCBI Accession
- NM_206861, NP_996743
Antigène
-